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and herpes zoster skin lesions. Treatment was made with
meropenem, amphotericin and acyclovir. In January 2014,ntroduction
etinal vein occlusion is the second most common cause
f visual loss due to retinal vascular disease after diabetic
etinopathy.1 Among the risk factors described, it is well
nown that the hypercoagulable state present in neoplasias
an culminate in vein occlusion. It is described that any ocular
tructure may be involved in acute leukemia2; involvement
f the choroid and retina is the most common. However,
eukemic cells can inﬁltrate the conjunctiva and lacrimal
lands, producing obvious masses. Karesh et al. published a
wo year prospective study of newly diagnosed adults with
cute myeloid leukemia; 64% of patients had retinal or optic
erve abnormalities where hemorrhages and cotton wool
pots (a consequence of nerve ﬁber ischemia) were the most
requent ﬁndings.3 The association between central retinal
ein occlusion and acute lymphoblastic leukemia (ALL)
elapse has rarely been described though.4–6 We  hereby report
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eserved.a case of central retinal vein occlusion as the presenting
manifestation of relapse in ALL.
Case  report
A 59-year-old female was diagnosed with ALL in November
2013. At that time, she had the following laboratory results:
hemoglobin: 8.7 g/dL; red blood cells: 2.95 × 109/L; MCV: 89 fL;
total leukocytes: 18.66 × 109/L; lymphocytes: 5.374 × 109/L;
segmented neutrophils: 2.930 × 109/L; blasts: 9143cells/L;
uric acid: 5.2 mg/dL; lactic dehydrogenase: 1672 U/L; creati-
nine: 3.1 mg/dL; and urea: 83 mg/dL. She received volemic
resuscitation for tumor lysis syndrome. Subsequently, she
developed pneumonia caused by Cryptococcus neoformansorto Alegre, RS, Brazil.
after completing treatment for the infections, she was sub-
mitted to chemotherapy induction using the hyperCVAD
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howFigure 1 – Fluorescein angiography s
regimen – course A (cyclophosphamide, vincristine, doxoru-
bicin and dexamethasone). Immunophenotyping performed
in February 2014 showed remission of the disease.
In March 2014 she presented febrile neutropenia and
typhlitis. Empiric treatment with cefepime was started and
the hyperCVAD regimen was interrupted. Blood culturesing occlusion of central retinal vein.
identiﬁed Escherichia coli and Klebsiella pnemoniae.  Treatment
was  completed on April 20th 2014.After hospital discharge, she was submitted to outpatient
re-induction therapy with the adapted Berlin-Frankfurt-
Munster (BFM) protocol (dexamethasone, vincristine, doxoru-
bicin and l-asparaginase) in June 2014. In July she was unable
er. 2 0
t
t
t
p
d
h
l
T
t
i
t
r
c
b
(
3
t
t
w
r
t
C
e
(
c
b
p
b
b
M
c
C
A
e
t
c
a
b
s
c
e
i
m
D
T
n
rrev bras hematol hemot
o complete the fourth cycle of therapy due to hematological
oxicity (hemoglobin: 9.0 g/dL; red blood cells: 2.71 × 109/L;
otal leukocytes: 0.870 × 109/L; neutrophils: 0.628 × 109/L; and
latelets: 13 × 109/L).
In August 2014 she came to our hospital emergency
epartment complaining of a headache of the right side of
er head, sensitivity to light, nausea, vomiting and visual
oss in the right eye that had started four days previously.
he neurological exam showed no abnormality, except for
he eye fundus examination, which revealed papilledema,
ntraretinal peripapillary and inframacular hemorrhage in
he right eye. The left eye presented a pre-retinal hemor-
hage.
Laboratory exams did not reveal any abnormality. A
oagulation panel showed platelets 154 × 109/L; prothrom-
in time activity: 100%; international normalization ratio
INR): 1.00; and activated partial thromboplastin time:
6.6 s.
A nuclear magnetic resonance image  (MRI) was made, and
he only abnormality was a hypointense lesion evidenced in
he T2 sequence in the right temporal posterior region, which
as probably a sequelae of a previous hemorrhagic infarct.
She was then submitted to a ﬂuorescein angiography that
evealed occlusion of the central retinal vein (Figure 1).
In order to exclude any infectious etiology, a lumbar punc-
ure was made, with a normal opening pressure (150 cmH2O).
erebrospinal ﬂuid analysis evidenced low glucose lev-
ls (28 mg/dL and 89 mg/dL in blood); high protein levels
89 mg/dL); cellularity 2520 cells/L; 94% blasts; 5% mono-
ytes; and red blood cells: 220 cells/L. Cultures for fungus,
acteria and cytomegalovirus antigenemia and herpes virus
olymerase chain reaction (PCR) were all negative.
She was not taking any drug that would potentially be capa-
le of inducing retinal vein occlusion.
In order to complete the evaluation of possible intracere-
ral vein thrombosis, the patient was submitted to a vascular
RI  that revealed thickening of the right optic nerve and optic
hiasm protuberance.
Immunophenotyping of the liquor had predominance of
D10, CD19, DC22, CD34, HLA DR cells, suggesting B lineage
LL. Lymphoblasts were identiﬁed in the cytopathological
xam and bone marrow cytology conﬁrmed medullar inﬁltra-
ion.
After conﬁrming neurological relapse of ALL, intrathecal
hemotherapy was given with dexamethasone, cytarabine
nd methotrexate. She had complete remission of headache,
ut had no improvement of her visual loss.
A magnetic resonance angiography of the central nervous
ystem (CNS) was carried out to exclude other possible vas-
ular thrombosis, but no alteration was found in the exam,
xcept for inﬁltration of the right optic nerve.
She was discharged from hospital after two sessions of
ntrathecal chemotherapy, and continues outpatient treat-
ent.iscussion
here are few cases reported in the literature showing ocular
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even though it is a consequence of CNS involvement with
severe prognosis. In the case reported herein, the patient had a
headache associated with visual loss, which strongly suggests
CNS damage. Once her ophthalmologic exam showed only
central retinal vein occlusion (CRVO), the clinical discussion
focused on the etiology of the underlying process: whether
it was a consequence of a hypercoagulable state or due to
direct invasion of neoplastic cells since both conditions can
culminate in CRVO.
In order to elucidate this question, a magnetic resonance
angiography was performed to exclude other possible vein
occlusions in the CNS, but the only ﬁnding was optic nerve
inﬁltration, which had not been evident until this moment.
It has already been described that MRI is useful in the early
detection of ocular involvement.7
Even though CRVO is related with an hypercoagulable state,
all the cases described in the literature that associate CRVO
with ALL are secondary to an inﬁltration of leukemic cells.4–6
All cases show inﬁltration of the optic disk preceding vessel
occlusion.
Treatment described in these cases consists in intrathecal
chemotherapy and radiotherapy.8,9 There is no beneﬁt in pre-
scribing vascular endothelial growth factor (VEGF) inhibitors
in these cases, as there is combined damage of the vein cir-
culation and the optic nerve conduction; the latter can cause
irreversible visual loss.10
Conclusion
CNS relapse can precede hematological signs and symptoms,
and regular ophthalmologic exams should be instituted in
patients with ALL. If ocular symptoms are present and the
ophthalmologic exam is normal, a MRI should be considered.
In cases of ALL and retinal vessel occlusion, always con-
sider optic nerve inﬁltration and rapidly institute treatment
with intrathecal chemotherapy and radiotherapy to avoid irre-
versible damage.
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